{"filings":[{"id":470558,"accession_number":"0001193125-26-226623","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2026-05-15T20:05:07+00:00","items":["5.02"],"status":"ready","headline":"WW International settles with former CEO Tara Comonte for $1.85M","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Settlement payment of $1,850,000 in two installments: $545,205.48 now, $1,304,794.52 by Oct 1, 2026.","Additional $150,000 for attorneys' fees paid directly to Comonte's legal counsel.","Mutual release of claims, non-disparagement, cooperation, and confidentiality covenants included.","Comonte resigned as CEO effective March 31, 2026; settlement finalized May 14, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90936,"accession_number":"0001193125-26-210279","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"WW Q1 revenue $168M, net loss $52M; clinical subs up 46%; reaffirms FY guidance; plans debt prepayment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $168M, net loss $52M; adjusted EBITDA loss $1.8M vs prior adj EBITDA $26.9M (not comparable due to fresh start accounting).","End-of-period clinical subscribers 197K (+46% YoY); clinical subscription revenue $39M (+32% YoY).","Core+ subscribers 537K (+6% YoY); ARPU up 13% YoY due to mix shift to higher-value tiers.","Reaffirms FY2026 guidance: revenue $620-635M, Adj EBITDA $105-115M.","Expects to pay $37M cash in Q2 to reduce term loan principal by $42M; voluntary solicitation fully subscribed at 68.5% of par."],"consensus_eps_estimate":null,"consensus_eps_actual":-5.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":168261000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90935,"accession_number":"0001193125-26-178866","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2026-04-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Weight Watchers to use up to $40M to prepay term loan; reaffirms 2026 guidance","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Company intends to prepay $25M-$30M of term loan (annual cash sweep) due June 24, 2026.","Voluntary solicitation to prepay up to $10M at a discount, running April 27-30, 2026.","Reaffirms Q1 2026 subscriber estimates and full-year 2026 financial guidance from March 16."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90934,"accession_number":"0001193125-26-162712","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2026-04-20T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"WW International appoints healthcare executive Heather Thiltgen to Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Heather Thiltgen elected to Board effective April 20, 2026; Board expands to six members.","Thiltgen is President of Presbyterian Health Plan; brings expertise in GLP-1 therapy access and payor-provider landscape.","She will receive standard non-employee director compensation: $90,000 annual cash retainer plus $12,500 for Compensation Committee.","Thiltgen is expected to stand for election at the 2026 annual meeting; all six directors are independent.","Appointment reflects focus on integrating behavioral support and clinical care for weight health."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90933,"accession_number":"0001193125-26-161747","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2026-04-17T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"WW International director resigns; interim CEO compensation approved for CFO and COO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Director Michael Mason resigns effective April 13, 2026, for personal reasons; board size reduced from six to five.","CFO Felicia DellaFortuna and COO Jonathan Volkmann to serve as Interim Office of CEO, receiving $150k lump sum in April 2026.","If they continue in IOCE after July 1, 2026, each gets a $50k monthly fee; pro-rated repayment required on early exit.","Annual bonus targets raised from 50% to 75% of base salary for both DellaFortuna ($600k base) and Volkmann ($495k base), effective for 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90930,"accession_number":"0001193125-26-148893","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K/A","filed_at":"2026-04-09T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Weight Watchers appoints new directors to committees; no interim CEO, continues Office of the CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lisa Gavales appointed to Compensation & Benefits and Strategy & Finance committees; Sue Gove to Audit and Nominating & Governance committees.","Board will not appoint interim CEO; Office of the CEO (CFO DellaFortuna and COO Volkmann) continues with support from new directors.","Permanent CEO search is ongoing with the assistance of a leading executive search firm.","Both new directors, Gavales and Gove, are independent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90932,"accession_number":"0001193125-26-144543","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2026-04-07T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Weight Watchers appoints Lisa Gavales and Sue Gove to board, expands to 6 members","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lisa Gavales (ex-Express CMO) and Sue Gove (ex-Bed Bath & Beyond CEO) elected independent directors effective April 7, 2026.","Board size increased to six directors, all independent; they will stand for election at the 2026 annual meeting.","Standard non-employee director compensation: $90k annual cash retainer, $12.5k per committee, and $135k RSU grant (subject to election).","Gavales brings expertise in e-commerce, brand building; Gove adds financial oversight and turnaround experience.","Appointments follow a multi-month search to support strategic transformation into digital weight health."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90931,"accession_number":"0001193125-26-141944","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2026-04-03T23:59:59+00:00","items":["5.02","5.03","9.01"],"status":"ready","headline":"WW CEO Tara Comonte resigns; OCEO established; legal chief Cooke departs with $1.5M separation","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Tara Comonte resigned March 31, 2026; Board established Office of the CEO with CFO DellaFortuna and COO Volkmann effective April 3.","Chief Legal Officer Jacqueline Cooke resigns April 10; receives $1.5M cash separation plus health benefits; Debra Cotter succeeds her.","Directors Julie Bornstein and Fallon O'Connor resign April 1, not due to disagreement; Board reduced from 7 to 4 directors.","Bylaws amended to set minimum directors at 3 (down from 5), range 3 to 15; Transition Committee formed to find permanent CEO.","Company reaffirms Q1 2026 subscriber estimates and full-year 2026 financial guidance provided on March 16, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100787,"accession_number":"0001193125-26-107148","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2026-03-16T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Weight Watchers Q4 rev $163M, net loss $6M; clinical subs up 42%; FY2026 rev guidance $620-635M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 total revenue $163M (-12% YoY); net loss $6M vs income $25M YoY; adjusted EBITDA $18M (11.1% margin).","End of period subscribers 2.8M (-17%); clinical subs 130K (+42%); clinical sub revenue $27M (+32%).","FY2025 revenue and Adjusted EBITDA exceeded previously provided guidance.","FY2026 guidance: revenue $620-635M, Adjusted EBITDA $105-115M. Q1 subs ~2.65M total, ~200K clinical.","Company cites GLP-1 transformation; 2026 seen as inflection year for sustainable growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117090,"accession_number":"0001193125-25-330852","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-12-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"WW International grants PSUs, RSUs, and cash awards to executives; CFO salary raised to $600k","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Tara Comonte receives 54,000 target PSUs, 120,000 RSUs, and $3.78M target cash award.","Felicia DellaFortuna receives 8,100 PSUs, 18,000 RSUs, $567k cash target; salary raised to $600k.","Jacquie Cooke receives 7,800 PSUs, 17,333 RSUs, $546k cash target.","Awards vest based on stock price hurdles over a 3-year performance period (2026-2029)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117089,"accession_number":"0001193125-25-268049","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"WeightWatchers Q3 net loss $58M, revenue $172M; narrows FY guidance to higher end","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $172M, down 10.8% YoY; clinical subscription revenue $26M, up 35.3% YoY.","Net loss $58M including $53M income tax charge; Adjusted EBITDA $43M (24.9% margin).","End-of-period subscribers 3.0M, with 124K clinical subscribers; debt reduced ~$1.1B post-restructuring.","FY2025 guidance narrowed: revenue $695-700M; Adjusted EBITDA $145-150M (both at higher end)."],"consensus_eps_estimate":null,"consensus_eps_actual":-5.63,"consensus_revenue_estimate":null,"consensus_revenue_actual":184258000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133542,"accession_number":"0001193125-25-202191","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-09-12T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"WW International amends consulting agreement with former CPO Donna Boyer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Former CPO Donna Boyer entered second amendment to consulting agreement effective Sept 1, 2025.","Total cash compensation for consulting services set at $143,720; consulting expires Sept 30, 2025.","Boyer subject to indefinite confidentiality and work product assignment covenants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133541,"accession_number":"0001193125-25-177438","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-08-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"WeightWatchers emerges from reorganization, cuts debt $1.15B; Q2 combined revenue down 6%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Completed strategic reorganization on June 24, reducing debt by $1.15 billion and applying fresh-start accounting.","Q2 combined revenue $189M (-6% YoY); clinical revenue up 55% to $31M, driven by compounded semaglutide.","Combined end-of-period subscribers 3.2M (-17% YoY); clinical subscribers 127K (+56% YoY).","Predecessor net income $1,191M (includes reorganization items); Successor net income $1M.","FY 2025 guidance: combined revenue $685M-$700M, adjusted EBITDA $140M-$150M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":12167000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133540,"accession_number":"0001193125-25-156416","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-07-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"WeightWatchers completes financial reorganization, relists on Nasdaq; appoints new CMO and board members","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Completed financial reorganization with enhanced flexibility; relisted on Nasdaq under ticker WW on July 8, 2025.","Appointed Dr. Kim Boyd as Chief Medical Officer; she previously led at One Medical, Calibrate, and Nurx.","New board includes Mike Mason (former Eli Lilly president of Diabetes & Obesity), Fallon O’Connor-Brooks, and others.","Will launch a perimenopause/menopause program later in 2025 combining medical, nutritional, and community support.","Appointed Uta Knablein as Chief Product Officer; promoted Jacquie Cooke to CLO and Jon Volkmann to COO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150217,"accession_number":"0001193125-25-146171","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-06-25T23:59:59+00:00","items":["1.01","1.02","2.03","3.02","3.03","5.01","5.02","5.03","9.01"],"status":"ready","headline":"WW International exits Chapter 11; old equity canceled, $465M new term loan, new board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Emergence effective June 24, 2025; old common stock canceled, holders receive 900,000 of 10M new shares (9%).","New $465M senior secured term loan due 2030 replaces ~$1.116B prepetition term loan and $500M notes discharged.","Board reconstituted: five directors out, four new directors appointed (Eugene Davis, Carney Hawks, Michael Mason, Nikolaj Sjoqvist).","Company issues 10M new common shares: 9.1M to first lien creditors, 0.9M to prior equity holders.","Fiscal year changed to calendar year; quarterly periods adjusted effective from 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150216,"accession_number":"0001193125-25-142383","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-06-18T23:59:59+00:00","items":["1.03","7.01","9.01"],"status":"ready","headline":"WeightWatchers Chapter 11 plan confirmed; debt cut $1.15B, existing stockholders get 9% of new equity","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Court confirmed prepackaged plan on June 17, 2025; exit expected on or about June 24, 2025.","Debt reduced by ~$1.15B (over 70%); new $465M senior secured term loans due 2030 issued.","Existing common stock canceled; holders receive pro rata 9% of new common equity (~10M shares), subject to forfeiture if milestones missed.","First Lien Claimants get 91% of new equity (100% if milestones not met); General Unsecured Claims unimpaired.","Company continued operations throughout process; CEO Tara Comonte highlights enhanced financial flexibility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.95,"calibrated_materiality_score":0.95,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150215,"accession_number":"0001193125-25-139955","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-06-12T23:59:59+00:00","items":["1.03","5.07","9.01"],"status":"ready","headline":"WW International files amended Chapter 11 plan; existing equity to get 9% of new common","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amended Plan Supplement filed June 12: existing equity holders receive 9% of new common equity, subject to milestones; first lien holders get 91%.","Plan reduces long-term debt by ~$1.15B and annual interest payments by ~50% to ~$50M.","Stock delisted from Nasdaq on May 16; now trades on OTC Pink under WGHTQ.","At June 6 annual meeting, say-on-pay failed (3.6M for, 6.1M against); three Class III directors elected.","Company cautions equity holders may experience significant loss; chapter 11 cases pending."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150214,"accession_number":"0001193125-25-132797","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-06-02T23:59:59+00:00","items":["1.01","1.03","9.01"],"status":"ready","headline":"WW International files amended Chapter 11 plan; takeback debt all term loans; stock delisted to OTC","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Nasdaq delisting effective after Form 25; stock now trades OTC under WGHTQ since May 16.","RSA modified to remove option to elect senior secured term loans vs notes; all $465M takeback debt will be term loans.","Amended Chapter 11 plan filed May 30 with technical modifications and updated governing documents.","Company expects equity holders may experience significant loss if plan confirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150213,"accession_number":"0001193125-25-116958","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-05-09T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"WW International (WW) receives Nasdaq delisting notice due to Chapter 11 filing; trading suspended May 16","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified WW on May 9, 2025, that its common stock will be delisted following the Chapter 11 filing on May 6.","Trading of WW common stock will be suspended at the opening of business on May 16, 2025, unless an appeal is requested.","Company intends to appeal and seek listing of new common equity on Nasdaq or another exchange upon emergence from Chapter 11.","Following suspension, WW expects its common stock to trade on the OTC Pink Current Market, though no assurance is given."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150212,"accession_number":"0001193125-25-114307","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["1.01","1.03","2.04","7.01","9.01"],"status":"ready","headline":"WW International files prepackaged Chapter 11; equity holders to receive only 9% of reorganized company","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Filed Chapter 11 on May 6, 2025 with prepackaged plan supported by 72% of First Lien Creditors.","First Lien Claims (~$1.6B total) to be exchanged for $465M takeback debt and 91% of reorganized equity.","Common stock holders receive 9% of new equity, subject to forfeiture if milestones are missed.","Unsecured creditors (including trade vendors) will be paid in full in the ordinary course.","Plan requires court confirmation within 42 days; equity investment is highly speculative."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150211,"accession_number":"0001193125-25-113809","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"WW Q1 revenue down 9.7% to $186.6M; clinical revenue up 57%; in debt restructuring talks","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss improved to $72.6M ($0.91 EPS loss) from $347.9M ($4.39) YoY.","Clinical subscription revenue rose 57.1% to $29.5M; total subscribers fell 14.2% to 3.4M.","Adjusted EBITDAS surged to $26.9M from $7.2M; gross margin expanded 450 bps to 71.2%.","Substantive discussions with lenders/noteholders on debt-reduction plan expected imminently.","Cash and equivalents $236.3M including $171.3M drawn on revolver."],"consensus_eps_estimate":-0.309,"consensus_eps_actual":-0.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":186571000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169220,"accession_number":"0001193125-25-060217","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-03-21T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"WW International receives Nasdaq bid price deficiency notice; has 180 days to regain compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq letter on March 19, 2025 for failure to maintain minimum $1.00 bid price.","Stock closed below $1.00 for 30 consecutive trading days, triggering the deficiency.","Must achieve $1.00+ closing bid for 10 consecutive days before September 15, 2025.","Listing and trading continue on Nasdaq under 'WW' with no immediate effect.","Company will monitor bid price and consider options to regain compliance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169219,"accession_number":"0001193125-25-039199","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"WW International Q4 net income $25.1M vs loss; names Tara Comonte permanent CEO","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $184.4M (-10.5% YoY); subscription rev down 7.3%; clinical subscription rev $20.5M (+57.9%).","Q4 net income $25.1M vs loss $88.1M; adj. EPS $0.32 vs -$0.84; adj. EBITDAS margin 27.4% (+1109 bps).","Full-year revenue $785.9M; net loss $345.7M incl. $293.2M impairment; adj. operating income $104.8M.","3.3M end-of-period subscribers, including 92k clinical; targeting $100M run-rate cost savings by end of 2025.","Board appointed Tara Comonte as permanent President & CEO effective Feb 26, 2025 (was interim)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169218,"accession_number":"0001193125-25-019282","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2025-02-03T23:59:59+00:00","items":["2.03","8.01"],"status":"ready","headline":"WW International borrows remaining $121.3M under revolver; total debt $175M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Borrowed $121.3M, the full remaining capacity under senior secured revolver on Jan 31, 2025.","Aggregate revolver borrowings now $175M; includes ~$3.7M undrawn letters of credit.","Company states draw provides financial flexibility, not to address near-term liquidity.","Company plans to actively evaluate capital structure and explore balance-sheet-strengthening transactions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186256,"accession_number":"0001193125-24-266538","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2024-11-27T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"WW International appoints Felicia DellaFortuna as CFO, replacing Heather Stark effective Jan 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Heather Stark to cease as CFO on Dec 27, 2024; she receives $884,293 cash severance plus benefits, subject to release.","Felicia DellaFortuna named CFO effective Jan 1, 2025; base salary $500,000, sign-on bonus $175,000, target bonus 50% of base.","DellaFortuna's continuity agreement includes 3x cash severance in certain change-of-control scenarios.","Stark forfeits all unvested equity on departure; vested options exercisable within 90 days; 12-month non-compete and 24-month non-solicit apply."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186255,"accession_number":"0001193125-24-251689","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"WW International Q3 revenue $192.9M, operating loss $39M; subscribers down 8.8%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $192.9M (-10.2% YoY); subscription revenue $191.2M (-6.0%).","GAAP operating loss $39.0M vs income $30.6M; includes $57M franchise rights impairment.","Adjusted operating income $35.7M (-2.5%); adjusted EPS $0.24 (-60.6%).","End-of-period subscribers 3.7M (-8.8%); clinical subscribers up 71.5% to ~0.1M.","Interim CEO Tara Comonte acknowledges 'significant work' to unify solutions and restore growth."],"consensus_eps_estimate":null,"consensus_eps_actual":-4.67,"consensus_revenue_estimate":null,"consensus_revenue_actual":601508000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202887,"accession_number":"0001193125-24-227373","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2024-09-27T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"WW CEO Sistani departs; board member Comonte appointed interim CEO; FY2024 guidance reaffirmed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sistani steps down as CEO and director effective Sept 27; receives severance, transition services, coaching ($37.5k), and legal fees ($50k).","Tara Comonte, board member since June 2023, appointed interim President and CEO effective Sept 27.","Comonte's compensation: $125k/month base salary, $750k bonus (earlier of permanent CEO or six months), $500k RSU vesting monthly over six months.","Board reduced from nine to eight members following Sistani's resignation.","Company reaffirms full-year 2024 guidance for subscribers, revenue, adjusted operating income, and adjusted EBITDAS."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202886,"accession_number":"0001193125-24-190580","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","2.05","5.02","9.01"],"status":"ready","headline":"WeightWatchers Q2 revenue down 10.9% to $202.1M, announces $100M restructuring plan, CTO departs","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenues $202.1M (down 10.9% YoY); net income $23.3M (down 54.2%); EPS $0.29 (down 54.9%).","End of period subscribers 3.8M (down 6.1%); Clinical subscribers 81k (up 119.8% YoY).","Restructuring plan targeting $100M annual run-rate cost savings; expects $12-15M charges in H2 2024.","CTO Pierre-Olivier Latour to depart Aug 9, 2024; severance up to ~$427k plus salary continuation."],"consensus_eps_estimate":null,"consensus_eps_actual":-4.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":408621000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219080,"accession_number":"0001193125-24-147179","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K/A","filed_at":"2024-05-24T23:59:59+00:00","items":["5.07","5.03","9.01"],"status":"ready","headline":"WW International corrects 8-K: majority voting proposal rejected; Articles of Correction filed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Proposal 4 (majority director voting) failed: 28.7M for, 454.5K against, required majority of outstanding shares.","Company filed Articles of Correction on May 24 to undo the amendment that was erroneously filed on May 13.","Directors Denis Kelly, Julie Rice (Class II) and Tara Comonte, William Shrank (Class I) elected with >27.9M votes each.","Say-on-pay passed with 16.3M for vs 12.9M against; auditor PwC ratified with 50.5M for.","Proposal 5 (delete controlling shareholder provisions) failed; broker non-votes initially misreported and corrected."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219083,"accession_number":"0001193125-24-143905","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2024-05-21T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"WW International CMO Amanda Tolleson to depart June 4; separation agreement includes $450K payment","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Amanda Tolleson, Chief Marketing Officer, leaves WW International effective June 4, 2024.","Separation agreement provides cash payment of up to $450,000 (1x salary) paid over 12 months.","Unvested equity awards forfeited; employer 401(k) matching contributions vest immediately.","Tolleson subject to one-year non-compete and non-solicitation; perpetual confidentiality covenant.","Tolleson released all claims against the Company and affiliates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219082,"accession_number":"0001193125-24-137216","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"WW International annual meeting: shareholders reject controlling shareholder provision deletion, adopt majority voting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elected Denis Kelly & Julie Rice (Class II) and Tara Comonte & William Shrank (Class I) as directors.","Shareholders approved majority voting standard in uncontested director elections (28.7M for).","Shareholders rejected proposal to delete former controlling shareholder provisions from articles.","Advisory say-on-pay passed with ~55.8% support (16.3M for, 12.9M against).","Bylaws amended to update advance notice requirements and incorporate universal proxy rules."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219079,"accession_number":"0001193125-24-135310","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K/A","filed_at":"2024-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"WW International corrects Q1 subscriber metrics; Clinical subscribers overstated by 4k","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Clinical End of Period Subscribers corrected to 87k from 91k; Total End of Period Subscribers to 4.004M from 4.008M.","Clinical Paid Weeks corrected to 1.038M from 1.056M; Total Paid Weeks to 51.782M from 51.799M.","Error stemmed from double-counting of subscribers transitioning between Clinical and other plans; reporting framework revised.","No other financial information, including revenues and EPS, was affected.","FY 2024 guidance reaffirmed: total subscribers 3.8-4.0M, Clinical subscribers 140k-160k, and expectation for subscription revenue growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219081,"accession_number":"0001193125-24-129351","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"WW Q1 2024: Revenue $206.5M, op loss $269.3M on $258M impairment; subscriber flat 4.0M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $206.5M (-14.6% YoY); subscription revenue $204.1M (-3.3%); other revenue $2.5M (-92%).","Operating loss $269.3M from $258M non-cash intangible impairment; adjusted operating loss $5.6M.","Net loss $347.9M ($4.39 EPS) vs $118.7M ($1.68) prior year.","End period subscribers 4.0M flat YoY; clinical subscribers 91K (from zero).","FY2024 guidance: total subscribers 3.8-4.0M, clinical 140-160K; revenue guidance maintained."],"consensus_eps_estimate":null,"consensus_eps_actual":-4.39,"consensus_revenue_estimate":null,"consensus_revenue_actual":206548000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238964,"accession_number":"0001193125-24-067973","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2024-03-14T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"WW on track to beat Q1 fiscal 2024 guidance for Clinical subscribers","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company disclosed to employees it expects to exceed previously issued Q1 2024 guidance for end-of-period Clinical subscribers.","Forward-looking statement subject to risks detailed in the annual report on Form 10-K filed February 28, 2024.","No specific subscriber numbers or revised guidance range provided in the disclosure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238963,"accession_number":"0001193125-24-050668","cik":105319,"company_name":"WW INTERNATIONAL, INC.","ticker":"WW","form_type":"8-K","filed_at":"2024-02-28T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"WW Q4 net loss $88.1M (-$1.11 EPS); Oprah Winfrey leaves board, donates stock","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $206.0M (down 7.6% YoY); net loss $88.1M vs $35.8M loss in prior year.","End of period subscribers 3.8M (+7% YoY), including 67k clinical subscribers.","FY2024 guidance: total subscribers 3.8-4.0M, clinical subscribers 140k-160k.","Oprah Winfrey will not stand for re-election at May 2024 annual meeting; board reduces to 9.","Winfrey will donate all her WW stock to National Museum of African American History and Culture."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":889551000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":93590000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}